References
- Cupp M. Analgesic options for patients with allergic-type opioid reactions. Pharmacist's Letter/Prescriber's Letter. 2006;22:22021.
- Boyden J, Connor S, Otolorin L, et al. Nebulized medications for the treatment of dyspnea: a literature review. J Aerosol Med Pulm Drug Deliv. 2015;28:1–19.
- Coyne P, Viswanathan R, Smith T. Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea. J Pain Symptom Manage. 2002;23:157–160.
- Bausewein C, Simon S. Inhaled nebulized and intranasal opioids for the relief of breathlessness. Curr Opin Support Palliat Care. 2014;8:208–212.
- Graff G, Stark J, Grueber R. Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient. Respiration. 2004;71:646–649.
- Smith T, Coyne P, French W, et al. Failure to Accrue to a study of nebulized fentanyl for dyspnea: lessons learned. J Palliat Med. 2009;12:771–772.
- Penson RT, Joel SP, Roberts M, Gloyne A, Beckwith S, Slevin ML. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide. Br J Clin Pharmacol. 2002;53:347–354.
- Kotrach H, Bourbeau J, Jensen D. Does nebulized fentanyl relieve dyspnea during exercise in healthy man? J Appl Physiol. 2015;118:1406–1414.
- Farr SJ, Otulana BA. Pulmonary delivery of opioids as pain therapeutics. Adv Drug Deliv Rev. 2006;58:1076–1088.
- Chrubasik J, Wust H, Friedrich G, Geller E. Absorption and bioavailability of nebulized morphine. Br J Anaesth. 1988;61:228–230.
- Mather LE, Woodhouse A, Ward ME, Farr SJ, Rubsamen RA, Eltherington LG. Pulmonary administration of aerosolised fentanyl: pharmacokinetic analysis of systemic delivery. Br J Clin Pharmacol. 1998;46:37–43.
- Hung OR, Whynot SC, Varvel JR, Shafer SL, Mezei M. Pharmacokinetics of inhaled liposome-encapsulated fentanyl. Anesthesiology. 1995;83:277–284.
- Pattinson KT. Opioids and the control of respiration. Br J Anaesth. 2008;100:747–758.
- Qaseem A, Snow V, Shekelle P, Casey DE, Cross JT, Owens DK. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008;148:141–146.
- Viola R, Kiteley C, Lloyd NS, Mackay JA, Wilson J, Wong RKS. The management of dyspnea in cancer patients: a systematic review. Support Care Cancer. 2008;16:329–337.
- Descotes J, Choquet-Kastylevsky G. Gell and Coombs's classification: is it still valid? Toxicology. 2001;158(1–2):43–9.